The Australian share market has been impacted by the downturn of Wall Street due to increasing sentiment that interest rates will remain high for a longer period. The S&P/ASX 200 fell by...
The Australian Securities Exchange (ASX) experienced a broad decline on Tuesday, with the energy sector being the only one to close higher. Local shares fell by almost half a percent as...
An analyst from HSBC downgraded Alkem Laboratories Ltd (NS: ALKE) from 'buy' to 'hold' with a price target of INR3945.00. Prior to this rating, Alkem Laboratories Ltd had 4 buy ratings, 9...
An analyst from HSBC maintained Alkem Laboratories Ltd (NS: ALKE) at 'buy' with a price target of INR3945.00 from a prior price target of %currency%%price%. Prior to this rating, Alkem...
An analyst from Nomura/Instinet downgraded Alkem Laboratories Ltd (NS: ALKE) from 'buy' to 'neutral' with a price target of INR3632.00 from a prior price target of...
An analyst from HSBC maintained Alkem Laboratories Ltd (NS: ALKE) at 'buy' with a price target of INR3605.00 from a prior price target of %currency%%price%. Prior to this rating, Alkem...
A Citi analyst maintained Alkem Laboratories Ltd (NS: ALKE) at Buy and a price target of $14.50 from a prior price target of %currency%%price%. Prior to this rating, Alkem Laboratories...
An Investec analyst maintained Alkem Laboratories Ltd (NS: ALKE) at Hold and a price target of $3280.00. Prior to this rating, Alkem Laboratories Ltd had 11 buy ratings, 4 hold ratings,...
A Bernstein analyst maintained Alkem Laboratories Ltd (NS: ALKE) at Market Perform and a price target of $2917.00. Prior to this rating, Alkem Laboratories Ltd had 11 buy ratings, 4 hold...
Lucknow, Oct 10 (IANS) The Indian Institute of Management, Lucknow (IIM-L) has scored 100 per cent placement in its summer placement drive. The drive -- held for the 38th batch of Post...
By Aditya Raghunath Investing.com -- Brokerage firm Motilal Oswal Financial Services Ltd (NS:MOFS) has recommended a buy on two pharma stocks that it thinks can give returns of up to 23% in...
By Aditya Raghunath Investing.com -- Mutual fund trades are a strong indicator of the potential of a stock. SEBI data says that mutual funds bought Rs 5,526 crore worth net equities in...
March 30 (Reuters) - Alkem Laboratories Ltd ALKE.NS :* AGREED IN PRINCIPLE TO SUBSCRIBE TO A PARTNERSHIP INTEREST IN ABCD TECHNOLOGIES LLP* DEAL CONSIDERATION IN FORM OF CASH INFUSION AS...
March 15 (Reuters) - Alkem Laboratories Ltd ALKE.NS :* LAUNCHES BRIVARACETAM IN INDIA UNDER BRAND NAME "BRIVASURE" FOR TREATMENT OF EPILEPSY...
Feb 5 (Reuters) - Alkem Laboratories Ltd ALKE.NS :* ALKEM LABORATORIES LTD - DECLARED INTERIM DIVIDEND OF 25 RUPEES PER SHARE* ALKEM LABORATORIES LTD DEC QUARTER CONSOL NET PROFIT 4.51...
Nov 6 (Reuters) - Alkem Laboratories Ltd ALKE.NS :* SEPT-QUARTER CONSOL NET PROFIT 4.72 BILLION RUPEES VERSUS 3.71 BILLION RUPEES YEAR AGO* SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS...
Aug 5 (Reuters) - Alkem Laboratories Ltd ALKE.NS :* ALKEM LABORATORIES LTD SAYS LAUNCHES FAVIPIRAVIR IN INDIA UNDER BRAND NAME "ALFLUENZA" FOR TREATMENT OF MILD TO MODERATE COVID-19....
June 5 (Reuters) - Alkem Laboratories Ltd ALKE.NS :* MARCH-QUARTER CONSOL NET PROFIT 1.89 BILLION RUPEES VERSUS 1.67 BILLION RUPEES YEAR AGO* MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS...
May 12 (Reuters) - Alkem Laboratories Ltd ALKE.NS :* US FDA HAS ISSUED AN ESTABLISHMENT INSPECTION REPORT (EIR) FOR MANUFACTURING FACILITY LOCATED AT ST. LOUIS, USA* INSPECTION HAS NOW...
March 13 (Reuters) - Alkem Laboratories Ltd ALKE.NS :* CLOSURE OF U.S. FDA INSPECTION AT CO'S MANUFACTURING FACILITY IN BADDI,...
Feb 21 (Reuters) - Alkem Laboratories Ltd ALKE.NS :* ALKEM LABORATORIES LTD SAYS US FDA HAD CONDUCTED AN INSPECTION AT MANUFACTURING FACILITY LOCATED AT BADDI FROM 17 FEB TO 21 FEB* ALKEM...
Feb 7 (Reuters) - Alkem Laboratories Ltd ALKE.NS :* ALKEM LABORATORIES LTD SAYS US FDA HAD CONDUCTED AN INSPECTION OF COMPANY'S MANUFACTURING FACILITY LOCATED AT ST. LOUIS, USA FROM...
Feb 7 (Reuters) - Alkem Laboratories Ltd ALKE.NS :* DEC-QUARTER CONSOL NET PROFIT 3.82 BILLION RUPEES VERSUS 2.03 BILLION RUPEES YEAR AGO* DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 21.82...
Nov 11 (Reuters) - Alkem Laboratories Ltd ALKE.NS :* SEPT QUARTER CONSOL NET PROFIT 3.71 BILLION RUPEES VERSUS 2.54 BILLION RUPEES YEAR AGO* SEPT QUARTER CONSOL REVENUE FROM OPERATIONS...
Nov 1 (Reuters) - Alkem Laboratories Ltd ALKE.NS :* ALKEM LABORATORIES LTD SAYS CLOSURE OF US FDA INSPECTION AT ALKEM'S MANUFACTURING FACILITIES LOCATED AT DAMAN, INDIA AND BADDI,...
Oct 22 (Reuters) - Alkem Laboratories Ltd ALKE.NS :* INDIA'S ALKEM LABS SAYS US FDA HAD CONDUCTED AN INSPECTION AT COMPANY'S BIOEQUIVALENCE CENTER LOCATED AT TALOJA, MAHARASHTRA;...
Sept 11 (Reuters) - Alkem Laboratories Ltd ALKE.NS :* INDIA'S ALKEM LABS SAYS US FDA HAS ISSUED AN ESTABLISHMENT INSPECTION REPORT FOR COMPANY'S MANUFACTURING FACILITY LOCATED AT...
Aug 30 (Reuters) - Alkem Laboratories Ltd ALKE.NS :* SAYS US FDA HAD CONDUCTED AN INSPECTION AT COMPANY'S MANUFACTURING FACILITY LOCATED AT DAMAN, INDIA* SAYS COMPANY HAS RECEIVED A...
Aug 12 (Reuters) - Alkem Laboratories Ltd ALKE.NS :* JUNE QUARTER CONSOL NET PROFIT 1.85 BILLION RUPEES VERSUS 1.36 BILLION RUPEES YEAR AGO* JUNE QUARTER CONSOL REVENUE FROM OPERATIONS...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
